No significant differences were found in terms of gender, age, infection, hemorrhage, FIB, combination chemotherapy, DS occurrence, severity of DS, PML-RARα genotype distribution, RBC transfusion, HGB level at diagnosis, renal function and the time to achieve remission (P> 0.05) between the two groups. This evidence concerns the gene CYGB and hemorrhage.